Publikationen in Zusammenarbeit mit Forschern von Linköping University (11)

2024

  1. Intraductal papillary neoplasms of the bile ducts: a comparative study of a rare disease in Europe and Nagoya, Japan

    HPB, Vol. 26, Núm. 4, pp. 565-575

2023

  1. Intraductal papillary neoplasms of the bile duct: a European retrospective multicenter observational study (EUR-IPNB study)

    International journal of surgery (London, England), Vol. 109, Núm. 4, pp. 760-771

2021

  1. Growth and development of islet autoimmunity and type 1 diabetes in children genetically at risk

    Diabetologia, Vol. 64, Núm. 4, pp. 826-835

2020

  1. Soluble urokinase plasminogen activator receptor (suPAR) levels predict damage accrual in patients with recent-onset systemic lupus erythematosus

    Journal of Autoimmunity, Vol. 106

2019

  1. Osteopontin and disease activity in patients with recent-onset systemic Lupus Erythematosus: Results from the SLICC Inception Cohort

    Journal of Rheumatology, Vol. 46, Núm. 5, pp. 492-500

  2. Post cholecystectomy bile duct injury: early, intermediate or late repair with hepaticojejunostomy – an E-AHPBA multi-center study

    HPB, Vol. 21, Núm. 12, pp. 1641-1647

2015

  1. Association of type and location of BRCA1 and BRCA2 mutations with risk of breast and ovarian cancer

    JAMA - Journal of the American Medical Association, Vol. 313, Núm. 13, pp. 1347-1361

2013

  1. GAD65 antigen therapy in recently diagnosed type 1 diabetes mellitus

    Diabetes Technology and Therapeutics

2012

  1. GAD65 antigen therapy in recently diagnosed type 1 diabetes mellitus

    New England Journal of Medicine, Vol. 366, Núm. 5, pp. 433-442

  2. Ovarian cancer susceptibility alleles and risk of ovarian cancer in BRCA1 and BRCA2 mutation carriers

    Human Mutation, Vol. 33, Núm. 4, pp. 690-702

2010

  1. Common breast cancer susceptibility alleles and the risk of breast cancer for BRCA1 and BRCA2 mutation carriers: Implications for risk prediction

    Cancer Research, Vol. 70, Núm. 23, pp. 9742-9754